Cervical Cancer Radiation ComplicationsSFPCERVIXNCT02733289
Standard Follow-up Program Cervix Cancer (SFP CERVIX)
An observational study of Cervical Cancer Radiation Complications, run by University Medical Center Groningen at 1 site in Netherlands.
Trial summary
Standard evaluation and follow-up data regarding complications of curative radiation treatment for cervical cancer. Read more about this study
- Who is it for?
- Any age, women only
- Conditions the study is for
- Cervical Cancer Radiation Complications
- How many people
- 10,000 participants
- Where
- 1 siteNetherlands
- Study dates
- Jun 2015to Dec 2040
- How long will I take part?
- 10 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- No healthy volunteers
- Child, Adult, Older adult
Study population: Every patient who receives curative radiotherapy for cervical cancer at the department of Radiotherapy at the UMCG.
Who may be able to join
- Every cervical cancer patient with curative intent for radiotherapy, treated at our department
Who cannot join
- Non-curative treatment
- Part of the treatment is given in another hospital
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Netherlands1 site, 1 recruiting
- Recruiting
University Medical Center Groningen
Groningen
Jannet Beukema, +31503610025, j.c.beukema@umcg.nl
About this study
Standard evaluation and follow-up data regarding complications of curative radiation treatment for cervical cancer.
- Conditions
- Cervical Cancer Radiation Complications
What is being measured
The primary outcome is the main question the study is designed to answer.
Complications
Physiological parameters, questionnaires
Measured: Five years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2016 (estimated)
- Study startJun 2015
- Primary completionDec 2040 (estimated)
- Study completionDec 2040 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cervical Cancer Radiation ComplicationsStudies of the same condition, open and under way.
- More trials run by University Medical Center GroningenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10,000 participants (estimated)
- Target duration
- 10 Years
Sponsor and investigators
- Lead sponsor
- University Medical Center Groningen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jannet Beukema, Principal investigator, Principal Investigator
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02733289
- Sponsor's protocol ID
- 201600207
- Acronym
- SFPCERVIX
- Status last verified
- Feb 2024
- First submitted
- 17 Mar 2016
- Last updated
- 28 Feb 2024
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Standard Follow-up Program Cervix Cancer (SFP CERVIX)
- ClinicalTrials.gov ID
- NCT02733289
- Acronym / sponsor ID
- SFPCERVIX / 201600207
- Conditions
- Cervical Cancer Radiation Complications
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 10,000 participants (estimated)
- Lead sponsor
- University Medical Center GroningenUniversity, hospital or other
- Study start
- Jun 2015
- Primary completion
- Dec 2040 (estimated)
- Study completion
- Dec 2040 (estimated)
- First posted
- 11 Apr 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Standard evaluation and follow-up data regarding complications of curative radiation treatment for cervical cancer.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 10 Years
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Every patient who receives curative radiotherapy for cervical cancer at the department of Radiotherapy at the UMCG.
Key inclusion criteria (1 listed)
- Every cervical cancer patient with curative intent for radiotherapy, treated at our department
Key exclusion criteria (2 listed)
- Non-curative treatment
- Part of the treatment is given in another hospital
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Complications
Time frame: Five years
Physiological parameters, questionnaires
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Feb 2024.
Related trials for Cervical Cancer Radiation Complications
RecruitingPhase 3
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Cervical Cancer, Adaptive Radiotherapy
Active, not recruitingPhase 1
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer
Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma
Not yet recruitingPhase 2
Adaptive Radiotherapy for Safe Hypofractionation
Cancer, Endometrial Cancer
Recruiting
Hydrogel Spacer During Definitive Radiotherapy for Cervical Cancer
Cervical Cancer
RecruitingPhase 1/2
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Jannet Beukema principal investigator
Principal Investigator
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cervical Cancer Radiation Complications, run by University Medical Center Groningen at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jannet Beukema (+31503610025, j.c.beukema@umcg.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Complications (time frame: Five years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.